NASDAQ: SURGSurgepays Inc Stock
$1.55-0.03 (-1.9%)
Updated Jan 17, 2025
SURG Price
$1.55
Fair Value Price
N/A
Market Cap
$31.25M
52 Week Low
$1.33
52 Week High
$9.23
P/E
-1.4x
P/B
0.94x
P/S
0.43x
PEG
N/A
Dividend Yield
N/A
Revenue
$83.60M
Earnings
-$22.90M
Gross Margin
5.2%
Operating Margin
-25.97%
Profit Margin
-27.4%
Debt to Equity
0.25
Operating Cash Flow
-$11M
Beta
0.75
Next Earnings
Mar 10, 2025
Ex-Dividend
N/A
Next Dividend
N/A
SURG Overview
SurgePays, Inc., a financial technology and telecommunications company, provides services to the underbanked community in the United States. Its blockchain platform utilizes a suite of financial and prepaid products to convert corner stores and bodegas into tech-hubs for underbanked neighborhoods. The company offers voice and SMS text messaging services to subsidized and direct retail prepaid customers, as well as to low-income consumers. It also offers subsidized mobile broadband services to consumers in California, Colorado, Florida, Illinois, Maryland, Mississippi, Missouri, Nevada, New Jersey, Ohio, Oklahoma, Rhode Island, Tennessee, and Texas, as well as prepaid wireless plans. In addition, the company provides marketing business intelligence, plaintiff generation, and case load management solutions primarily to law firms in the mass tort industry. Further, it operates a bilingual operations center offering the Company with sales support, customer service, IT infrastructure design, graphic media, database programming, software development, revenue assurance, lead generation, and other various operational support services. The company is headquartered in Bartlett, Tennessee.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SURG's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More
Zen Rating Component Grades
F
Value
F
Growth
D
Momentum
F
Sentiment
D
Safety
D
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important SURG news, forecast changes, insider trades & much more!
SURG News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SURG scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SURG is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SURG is good value based on its book value relative to its share price (0.94x), compared to the US Software - Application industry average (7.76x)
P/B vs Industry Valuation
SURG is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SURG due diligence checks available for Premium users.
Valuation
SURG price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.4x
Industry
33.11x
Market
30.45x
SURG price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.94x
Industry
7.76x
SURG is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SURG's financial health
Profit margin
Revenue
$4.8M
Net Income
-$14.3M
Profit Margin
-299.3%
SURG's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
SURG's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$41.5M
Liabilities
$8.2M
Debt to equity
0.25
SURG's short-term assets ($33.91M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SURG's short-term assets ($33.91M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SURG's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SURG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$13.3M
Investing
-$10.6M
Financing
-$873.7k
SURG's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SURG vs App Stocks
Surgepays Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.